Advanced BioMedical Technologies, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8a567992-332f-4de7-ad75-18d1cb91b385/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-446.6k | 2019-11-01 – 2020-10-31 | evidence 0001493152-21-002055 |
| FY 2019 | $-604.7k | 2018-11-01 – 2019-10-31 | evidence 0001493152-20-004401 |
| FY 2018 | $-634.0k | 2017-11-01 – 2018-10-31 | evidence 0001493152-19-001841 |
| FY 2017 | $-403.6k | 2016-11-01 – 2017-10-31 | evidence 0001493152-18-001918 |
| FY 2016 | $-461.3k | 2015-11-01 – 2016-10-31 | evidence 0001387131-17-000831 |
| FY 2015 | $-605.2k | 2014-11-01 – 2015-10-31 | evidence 0001387131-16-004238 |
| FY 2014 | $-617.8k | 2013-11-01 – 2014-10-31 | evidence 0001387131-16-004238 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Advanced BioMedical Technologies, Inc. — all facts · Net Income